Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNanoViricides Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2027 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2027 | 1 | -$0.09 | -$0.09 | -$0.09 |
NanoViricides Inc Earnings Date And Information
NanoViricides Inc last posted its earnings results on Thursday, May 14th, 2026. The company reported $-0.09 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0.01. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NanoViricides Inc has generated $-1 earnings per share over the last year ($-0.63 diluted earnings per share) and currently has a price-to-earnings ratio of -3.05. NanoViricides Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
NanoViricides Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2026 | Q3 2026 | N/A | -$0.09 | N/A | $0 | $0 |
| 02/17/2026 | Q2 2026 | -$0.14 | -$0.11 | 0.03 | $0 | $0 |
| 11/14/2025 | Q1 2026 | -$0.18 | -$0.10 | 0.08 | $0 | $0 |
| 09/29/2025 | Q4 2025 | -$0.20 | -$0.13 | 0.07 | N/A | $0 |
| 05/15/2025 | Q3 2025 | -$0.19 | -$0.14 | 0.05 | N/A | $0 |
| 02/14/2025 | Q2 2025 | -$0.18 | -$0.14 | 0.04 | N/A | $0 |
| 11/14/2024 | Q1 2025 | -$0.17 | -$0.23 | -0.06 | N/A | $0 |
| 09/27/2024 | Q4 2024 | -$0.20 | -$0.20 | 0 | N/A | $0 |
| 05/14/2024 | Q3 2024 | -$0.19 | -$0.16 | 0.03 | N/A | $0 |
| 02/14/2024 | Q2 2024 | -$0.19 | -$0.18 | 0.01 | N/A | $0 |
| 11/14/2023 | Q1 2024 | -$0.17 | -$0.17 | 0 | N/A | $0 |
| 10/13/2023 | Q4 2023 | -$0.17 | -$0.31 | -0.14 | N/A | $0 |
| 05/15/2023 | Q3 2023 | -$0.17 | -$0.14 | 0.03 | N/A | $0 |
| 02/14/2023 | Q2 2023 | -$0.16 | -$0.14 | 0.02 | N/A | $0 |
| 11/14/2022 | Q1 2023 | -$0.17 | -$0.13 | 0.04 | N/A | $0 |
| 10/13/2022 | Q4 2022 | -$0.23 | -$0.15 | 0.08 | N/A | $0 |
| 05/16/2022 | Q3 2022 | N/A | -$0.16 | N/A | N/A | $0 |
| 02/14/2022 | Q2 2022 | -$0.22 | -$0.17 | 0.05 | N/A | $0 |
| 11/15/2021 | Q1 2022 | -$0.20 | -$0.23 | -0.03 | N/A | $0 |
| 10/12/2021 | Q4 2021 | N/A | -$0.19 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NanoViricides Inc Earnings: FAQ's
The conference call for NanoViricides Inc's latest earnings report can be listened to online.
The conference call transcript for NanoViricides Inc's latest earnings report can be read online.
NanoViricides Inc (:NNVC) has a recorded net income of $-9,466,966.NanoViricides Inc has generated $-0.63 earnings per share over the last four quarters.
NanoViricides Inc (:NNVC) has a price-to-earnings ratio of -3.05 and price/earnings-to-growth ratio is -0.06.